The flow cytometry instruments market focused on the United States is projected to attain significant revenue by 2022, according to a report on Radiant Insights, Inc. Factors such as accurate assays for detecting cancer, cell-based assays, and prevalence of chronic diseases are expected to encourage the market to expand at a significant CAGR from 2016 to 2022 (forecast period).
Flow cytometry is a technology employed in the biotechnology sector for cell sorting, cell counting, biomarker detection, and other uses by passing it through an electronic detection apparatus. Its advantages such as user-friendliness, fluorescence capabilities, and use in specialized research and clinical applications can drive market growth over the forecast period. Instances of external funding to drive research for in-vitro molecular diagnosis is projected to open up new market avenues.
Automated flow cytometers are gaining prominence in the United States market due to rising incidence of chronic diseases like cancer. The BD LSRFortessa X-20 flow cytometer, a product by BD Biosciences, is an instrument that can detect twenty parameters simultaneously with a range of nearly 34 laser choices. It can be custom designed to fit specific research needs of organizations. Miltenyi Biotec, one of the market players, has launched the The MACSQuant X, which can work at high speeds and is best suited for large-scale operations. The flow cytometer is integrated with a software to aid lab workers in scheduling sample layouts and labels.
The United States flow cytometry instruments market is segmented by product, application, and region. On the basis of product, the market is bifurcated into cell sorters and cell analyzers. The cell analyzers segment is anticipated to gain a significant market share due to use of automated cell counters to diagnose blood cells with greater precision. The cell sorting segment can reportedly attain high earnings due to adoption of sorting techniques in research activities and rising prevalence of HIV/AIDS.
Major applications include research, industrial, and clinical. The research application segment had accounted for a major share in the market in 2016 due to growing research and development (R&D) activities focused on cancer and other chronic diseases. Clinical is expected to be the fastest growing application segment due to high demand for diagnostic tools and benefits of these tools in determining the nature of a disease.
Regions covered in the US flow cytometry instruments industry are the Midwest, the West, Southwest, the South, the Middle Atlantic, and New England. The regions housing major research companies such as Luminex Corporation and Beckman Coulter can contribute maximum revenue to the market.
Get PDF request sample @ https://goo.gl/WkdR6U
Prominent market players comprise Merck KGaA; Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Beckman Coulter Inc., and BD Life Sciences. The market is highly competitive with companies focusing on innovations and creating alliances to increase their market share. For instance, BD Life Sciences entered into an agreement with Seegene Inc. in 2015 to enhance the development of real-time polymerase chain reaction (PCR) reagents for the BD Max system. New entrants may find it difficult to penetrate the market due to a lack of a strong distribution system.
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States